Blackstone, Bain Capital and Taisho Pharmaceutical are among the final bidders for Takeda Pharmaceutical’s consumer drug business in Japan, a deal that could be worth up to 400 billion yen …
( read original story …)
The Japan News
Blackstone, Bain Capital and Taisho Pharmaceutical are among the final bidders for Takeda Pharmaceutical’s consumer drug business in Japan, a deal that could be worth up to 400 billion yen …
( read original story …)